Double cord blood transplantation: Co-operation or competition?

Hematology Reports

Volumn 3, Issue 1, 2011, Pages 18-19

  Neokleous, Nikolaos ^a   Sideri, Anastasia ^b   Peste Tsilimidos, Corina ^b  

^a LIMASSOL GENERAL HOSPITAL   (Cyprus)

^b HYGEIA HOSPITAL   (Greece)

Author keywords

Chimerism; Cord blood transplantation; Dominance; Engraftment

Indexed keywords

CD34 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL HOMING; CELL PROLIFERATION; CELL VIABILITY; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DOUBLE CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEALTH DISPARITY; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MESENCHYMAL STEM CELL; MORTALITY; NATURAL KILLER CELL; NONHUMAN; OUTCOME ASSESSMENT; SAFETY; UMBILICAL CORD BLOOD;

EID: 80052048818     PISSN: 20388322     EISSN: 20388330     Source Type: Journal    
DOI: 10.4081/hr.2011.e6     Document Type: Article

References (20)

1. Rocha V, Crotta A, Ruggeri A, et al. Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. Best Pract Res Clin Haematol 2010;23:223-229.
2. MacMillan ML, Weisdorf DJ, Brunstein CG, et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood 2009;113:2410-2415.
3. Verneris MR, Brunstein CG, Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versusleukemia effect in recipients of 2 units. Blood 2009;114:4293-4299.
4. Delaney C, Gutman JA, Appelbaum FR. Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications. Br J Haematol 2009;147:207-216.
5. Haspel RL, Kao G, Yeap BY, et al. Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation. Bone Marrow Transplant 2008;41:523-529.
6. Yen HJ, Chiou TJ, Hung GY, et al. Longterm mixed full-donor chimerism with dominance reversion after a double-unit cord blood transplant. Eur J Haematol 2008;80:366-367.
7. Kristt D, Gesundheit B, Stein J, et al. Quantitative monitoring of multi-donor chimerism: a systematic, validated framework for routine analysis. Bone Marrow Transplant 2010;45:137-147.
8. Verneris MR, Wagner JE. UCB and atmospheric noise. Blood 2010;115:754-755.
9. Gutman JA, Turtle CJ, Manley TJ, Heimfeld Set al. Single-unit dominance after double- unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit. Blood. 2010;115:757-765.
10. Avery S, Shi W, Lubin M, et al. Influence of infused cell dose and HLA-match on engraftment after double-unit cord blood allografts. Blood 2010;117:3277-3285.
11. Scaradavou A, Smith KM, Hawke R, et al. Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant 2010;16:500-508.
12. Nilsson SK, Johnston HM, Coverdale JA. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001; 97:2293-2299.
13. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haema-topoietic stem cell niche. Nature 2003;425:841-846.
14. Brunstein CG, Barker JN, Weisdorf DJ, et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant 2009;43:935-940.
15. Mold JE, Michaëlsson J, Burt TD, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008;322:1562-1565.
16. Eldjerou LK, Chaudhury S, Baisre-de Leon A, et al. An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood 2010; 116:3999-4006.
17. Willemze R, Rodrigues CA, Labopin M, et al. KIR-ligand incompatibility in the graftversus- host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia 2009;23: 492-500.
18. Kim DW, Chung YJ, Kim TG, et al. Cotransplantation of third-party mesenchymal stromal cells can alleviate single- donor predominance and increase engraftment from double cord transplantation. Blood 2004;103:1941-1948.
19. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol 2009;217: 318-324.
20. le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890-896.